IPR2017-00827 - Coherus Biosciences Inc v. Fraunhofer et al.Report Error
Details
PATENT NUMBER
APPL. NUMBER
14506576
STATUS
Procedural Termination
FILING DATE
2017-01-31
INSTITUTION DATE
N/A
TERMINATION DATE
2017-04-11
AUTHOR JUDGE
Timeline
Petition
Notice of Filing Date
Final Decision
2017
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Docket
| 1 | 2017-01-31 | Petitioner | Petition | PETITION FOR INTER PARTES REVIEW OF UNITED STATES PATENT NO. 9,085,619 PURSUANT TO 35 U.S.C. 311-319 AND 37 C.F.R. 42 |
| 2 | 2017-01-31 | Petitioner | Power of Attorney | Petitioner's Signed Power of Attorney |
| 1201 | 2017-01-31 | Petitioner | U.S. Patent No. 9,085,619 | |
| 1202 | 2017-01-31 | Petitioner | Declaration of Klaus-Peter Radtke, Ph.D. | |
| 1203 | 2017-01-31 | Petitioner | U.S. Pub. No. 2016/0319011 | |
| 1204 | 2017-01-31 | Petitioner | U.S. App. 60/690,582 | |
| 1205 | 2017-01-31 | Petitioner | HUMIRA Label (Jan. 2003) | |
| 1206 | 2017-01-31 | Petitioner | HUMIRA Label (Jan. 2008) | |
| 1207 | 2017-01-31 | Petitioner | Declaration of David D. Sherry, M.D. | |
| 1208 | 2017-01-31 | Petitioner | Adalimumab Product Approval Information | |
| 1209 | 2017-01-31 | Petitioner | AbbVie Biotechnology Ltd., Annex A - The Humira Story | |
| 1210 | 2017-01-31 | Petitioner | U.S. Pub. No. 2003/0206898 | |
| 1211 | 2017-01-31 | Petitioner | Parslow 1997 | |
| 1212 | 2017-01-31 | Petitioner | Butler & Hamilton 1991 | |
| 1213 | 2017-01-31 | Petitioner | Jefferis et al. 1995 | |
| 1214 | 2017-01-31 | Petitioner | McDonnell 2015 | |
| 1215 | 2017-01-31 | Petitioner | Christensen 1966 | |
| 1216 | 2017-01-31 | Petitioner | Van Slyke 1922 | |
| 1217 | 2017-01-31 | Petitioner | Gokarn et al. 2006 | |
| 1218 | 2017-01-31 | Petitioner | Gelfand 2006 | |
| 1219 | 2017-01-31 | Petitioner | Fransson & Espander-Jansson 1996 | |
| 1220 | 2017-01-31 | Petitioner | U.S. Pub. No. 2003/0138417 | |
| 1221 | 2017-01-31 | Petitioner | Laursen et al. 2006 | |
| 1222 | 2017-01-31 | Petitioner | Frenken et al. 1993 | |
| 1223 | 2017-01-31 | Petitioner | Nozaki & Tanford 1967 | |
| 1224 | 2017-01-31 | Petitioner | Olthuis et al. 1994 | |
| 1225 | 2017-01-31 | Petitioner | GAMIMUNE Label (Oct. 2005) | |
| 1226 | 2017-01-31 | Petitioner | Physicians Desk Reference (56th ed. 2002) | |
| 1227 | 2017-01-31 | Petitioner | U.S. Prosecution History of App. No. 14/506,576 | |
| 1228 | 2017-01-31 | Petitioner | U.S. Prosecution History of App. No. 13/774,735 - PART 2 of 2 | |
| 1229 | 2017-01-31 | Petitioner | U.S. Prosecution History of App. No. 12/325,049 - PART 5 of 6 | |
| 1230 | 2017-01-31 | Petitioner | U.S. Prosecution History of App. No. 61/004,992 | |
| 1231 | 2017-01-31 | Petitioner | Stoner et al. 2004 | |
| 1232 | 2017-01-31 | Petitioner | Fraunhofer Substantive Motion 3, Patent Interference No. 106,057 | |
| 1233 | 2017-01-31 | Petitioner | Schwartz 2003 | |
| 1234 | 2017-01-31 | Petitioner | U.S. Pub. No. 2004/0033535 | |
| 1235 | 2017-01-31 | Petitioner | Gebhart 2001 | |
| 1236 | 2017-01-31 | Petitioner | Carnahan et al. 2003 | |
| 1237 | 2017-01-31 | Petitioner | Press Release (Jan. 23, 2003) | |
| 1238 | 2017-01-31 | Petitioner | U.S. Pub. No. 2013/0273066 | |
| 1239 | 2017-01-31 | Petitioner | U.S. Pub. No. 2012/0028877 | |
| 1240 | 2017-01-31 | Petitioner | U.S. Pub. No. 2008/0311078 | |
| 1241 | 2017-01-31 | Petitioner | WO 2006/138181, Gokarn et al. | |
| 1242 | 2017-01-31 | Petitioner | U.S. Patent No. 6,090,382, Salfeld et al. | |
| 1243 | 2017-01-31 | Petitioner | Gottlieb 2005 | |
| 1244 | 2017-01-31 | Petitioner | Schwartzman & Morgan 2004 | |
| 1245 | 2017-01-31 | Petitioner | Granolleras et al. 1991 | |
| 1246 | 2017-01-31 | Petitioner | Development Pharmaceutics for Biotechnological and Biological Products (Oct. 21, 1999) | |
| 1247 | 2017-01-31 | Petitioner | Clinical Pharmacology and Biopharmaceutics Review(s), Application No. 125057/0, in Approval Package for Humira (Approved Dec. 31, 2002) | |
| 1248 | 2017-01-31 | Petitioner | Patent Owner's Preliminary Response, IPR2016-01018, Paper No. 9 | |
| 1249 | 2017-01-31 | Petitioner | A Bioworld Special Report: Biosimilars: U.S. Market Opportunities and Critical Strategies 2016 | |
| 1250 | 2017-01-31 | Petitioner | WO 1997/029131, Salfeld et al. | |
| 1251 | 2017-01-31 | Petitioner | HUMIRA Label (Nov. 2015) | |
| 1252 | 2017-01-31 | Petitioner | HUMIRA Label (Oct. 2016) | |
| 1253 | 2017-01-31 | Petitioner | SYNAGIS Label (July 2004) | |
| 1254 | 2017-01-31 | Petitioner | Vivaglobin Label (Jan. 2006) | |
| 1255 | 2017-01-31 | Petitioner | CNJ-016 (Vaccinia Immune Globulin Intravenous) Label (Jan. 2010) | |
| 1256 | 2017-01-31 | Petitioner | GAMMAGARD LIQUID Label (April 2005) | |
| 1257 | 2017-01-31 | Petitioner | OCTAGAM Label (Mar. 2004) | |
| 1258 | 2017-01-31 | Petitioner | Flebogamma Label (Jan. 2004) | |
| 1259 | 2017-01-31 | Petitioner | GAMUNEX Label (Nov. 2005) | |
| 1260 | 2017-01-31 | Petitioner | Privigen Label (Oct. 2016) | |
| 1261 | 2017-01-31 | Petitioner | HepaGam B Summary Basis for Approval (Jan. 2006) | |
| 1262 | 2017-01-31 | Petitioner | AVASTIN Label (Feb. 2004) | |
| 1263 | 2017-01-31 | Petitioner | TYSABRI Label (Nov. 2004) | |
| 1264 | 2017-01-31 | Petitioner | Vectibix Label (Sept. 2006) | |
| 1265 | 2017-01-31 | Petitioner | Campath Label (Aug. 2006) | |
| 1266 | 2017-01-31 | Petitioner | Akers et al. 2002 | |
| 1267 | 2017-01-31 | Petitioner | Cleland & Langer 1994 | |
| 1268 | 2017-01-31 | Petitioner | Hanna (Mar. 10, 2003) | |
| 1269 | 2017-01-31 | Petitioner | Handbook of Pharmaceutical Excipients (5th ed. 2006) | |
| 1270 | 2017-01-31 | Petitioner | Note for Guidance on Development Pharmaceutics (Jan. 28, 1998) | |
| 1271 | 2017-01-31 | Petitioner | Injection Tips (Archived Mar. 17, 2005) | |
| 1272 | 2017-01-31 | Petitioner | Dean, Lange's Handbook of Chemistry (9th ed. 1999) | |
| 1273 | 2017-01-31 | Petitioner | van de Putte, et al. (September 1998) | |
| 1274 | 2017-01-31 | Petitioner | HUMIRA Label (Oct. 2005) | |
| 1275 | 2017-01-31 | Petitioner | HUMIRA Label (Feb. 2008) | |
| 1276 | 2017-01-31 | Petitioner | HUMIRA Label (Feb. 2007) | |
| 1277 | 2017-01-31 | Petitioner | HUMIRA Label (Nov. 2006) | |
| 1278 | 2017-01-31 | Petitioner | Meadows & Hollowell (2008) | |
| 1279 | 2017-01-31 | Petitioner | ENBREL Label (Sept. 2002) | |
| 1280 | 2017-01-31 | Petitioner | ENBREL Label (Nov. 1998) | |
| 1281 | 2017-01-31 | Petitioner | REMICADE Label (Aug. 1998) | |
| 1282 | 2017-01-31 | Petitioner | Tsourounis (June 2005) | |
| 1283 | 2017-01-31 | Petitioner | U.S. Patent No. 6,696,056, Cheung et al. | |
| 1284 | 2017-01-31 | Petitioner | Summary Review for Regulatory Action, Sarah Yim, Division of Pulmonary, Allergy, and Rheumatology Products (U.S. FDA), of Humira (2015) | |
| 1285 | 2017-01-31 | Petitioner | Nash (2016) | |
| 3 | 2017-02-21 | Potential Patent Owner | Power of Attorney | Patent Owner's Power of Attorney |
| 4 | 2017-02-21 | Potential Patent Owner | Mandatory Notice | Patent Owner's Mandatory Notices |
| 5 | 2017-02-24 | Board | Notice of Filing Date | Notice of Accord Filing Date |
| 6 | 2017-02-27 | Potential Patent Owner | Other | Patent Owner's Updated Mandatory Notices |
| 7 | 2017-03-17 | Potential Patent Owner | Other | Patent Owner's Second Updated Mandatory Notices |
| 8 | 2017-03-23 | Petitioner | Other | Petitioner's Updated Mandatory Notices |
| 9 | 2017-04-07 | Petitioner | Other | Petitioner's Unopposed Motion to Dismiss Petitions Without Prejudice |
| 10 | 2017-04-07 | Board | Other | Order Conduct of the Proceeding |
| 11 | 2017-04-11 | Board | Final Decision | Termination Decision Document |
| 12 | 2017-05-25 | Petitioner | Other | PETITIONER'S REQUEST FOR REFUND OF POST-INSTITUTION FEES |
| 13 | 2017-06-05 | Board | Other | Notice of Refund |
Grounds Asserted